Clinical Characteristics and Continued Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Administration in EGFR-mutated Non-Small Cell Lung Cancer with Skeletal Metastasis

PURPOSE: The aim of this study was to analyze clinical characteristics of skeletal metastasis in epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) and treatment outcomes of continued EGFR tyrosine kinase inhibitor (TKI) therapy in patients presenting with skeletal met...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Sook-Hee, Kim, Yeon-Sil, Lee, Ji Eun, Kim, In-ho, Kim, Seung Joon, Han, Daehee, Yoo, Ie Ryung, Chung, Yang-Guk, Kim, Young-Hoon, Lee, Kyo-Young, Kang, Jin-Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946371/
https://www.ncbi.nlm.nih.gov/pubmed/26790969
http://dx.doi.org/10.4143/crt.2015.289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946371/
https://www.ncbi.nlm.nih.gov/pubmed/26790969
http://dx.doi.org/10.4143/crt.2015.289

Ejemplares similares